Skip to main content
Caplight Logo









2EyesVision

2EyesVision

Private
MadridHealthcare & Life Scienceshttps://2eyesvision.com

Last Round

Crowdfunding

Oct 29, 2025

Total Funding Raised

$420,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

2EyesVision operates in Healthcare & Life Sciences and is based in Madrid. Its latest recorded funding round was a Debt round in April 2025.

2EyesVision is an ophthalmic technology company that develops and commercializes innovative visual simulators, such as the SimVis Gekko, to help patients and clinicians make personalized decisions for cataract and presbyopia surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Patient Engagement

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

2EyesVision Comparables

Compare 2EyesVision with similar companies based on industry and business-model similarity.

2EyesVision comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VirtuaLens
81%
GreenMan
78%
Carl Zeiss Meditec AG
75%
Book a demo to see all comparables

For institutional investors. Book with your work email.

2EyesVision Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingOct 29, 2025
VC RoundApr 30, 2025
DebtApr 30, 2025
AcceleratorApr 5, 2021
VC RoundNov 26, 2020
Series A
Dec 12, 2017
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

2EyesVision Investors

Notable investors and investment history

2EyesVision investors
InvestorRounds
Empire State DevelopmentAccelerator
Luminate AcceleratorAccelerator
Empresa Nacional de InnovaciónDebt
Center for Technological Development and InnovationCrowdfunding, VC Round
Bullnet CapitalCrowdfunding, VC Round, Series A
Capital CellCrowdfunding
InnvierteVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 49% MoM.

  • Apr 20, 2026

    Monthly visitors grew 1366% MoM, reaching 9.4K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • recognized_asSep 15, 2026

    At ESCRS iNovation Day in United Kingdom on Sep 15th '26, 2EyesVision is voted Most Innovative Company in the "Simultaneous Vision IOLs" category, receiving 43% of the votes.

  • attends_eventSep 15, 2026

    In Sep '26, 2EyesVision attends ESCRS iNovation Day in United Kingdom and is voted Most Innovative Company in the “Simultaneous Vision IOLs” category.

  • launchesSep 12, 2026

    2EyesVision presents SimVis Gekko at CCOS 2026 in China from Sep 9–12 '26, giving Chinese ophthalmology professionals hands-on access to its real-world visual simulation for preoperative counseling and IOL simulation.

  • attends_eventSep 12, 2026

    2EyesVision attends CCOS 2026 in China in Sep '26 and presents SimVis Gekko, enabling Chinese ophthalmology professionals to experience real-world visual simulation.

  • hiresSep 8, 2026

    2EyesVision appoints Máximo Gómez as Chief Executive Officer in Spain on Sep 8th '26 to lead growth, business development and international expansion after he joins the company in 2025.

Book a demo to see all news

For institutional investors. Book with your work email.

2EyesVision Filings

Explore SEC and related filing metadata, where available.

2EyesVision filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about 2EyesVision's valuation, stock price, and market status.

Is 2EyesVision a public or private company?

2EyesVision is a private company.

What is the current stock price of 2EyesVision?

2EyesVision is a private company, so its shares have no public market price. Caplight tracks 2EyesVision's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is 2EyesVision worth (valuation)?

Valuation information for 2EyesVision is not publicly available.

Can I buy 2EyesVision stock?

2EyesVision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was 2EyesVision's last funding round?

2EyesVision's most recent funding round was Crowdfunding on October 29, 2025.

Who are the main investors in 2EyesVision?

Key investors in 2EyesVision include Bullnet Capital.

Will 2EyesVision IPO soon?

No public IPO plans have been announced for 2EyesVision.

How can I track 2EyesVision secondary market activity?

Caplight tracks bids, offers, and trades in 2EyesVision's shares on secondary markets.

Firmographic Details

HeadquartersMadrid
Employee Range15
Year Founded2015
Last FundingOct 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?